Trial intelligence / Profile preview

SUPRABLOC pilot randomized controlled trial

PACTR202110574604922Phase 2Completed

Sponsor
Department of Anaesthesiology and Critical Care, Stellenbosch University
Start
Oct 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of bupivacaine in Not applicable (2 arms), sponsored by Department of Anaesthesiology and Critical Care, Stellenbosch University. Primary endpoints: Proportion eligible after screening, Acceptance rate and 5 more. Started Oct 2019; status: completed.

02

Drugs

bupivacaine
03

Conditions

Not applicable

Beyond the preview

Go deeper on PACTR202110574604922.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202110574604922.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call